ISMRM 25th Annual Meeting & Exhibition • 22-27 April 2017 • Honolulu, HI, USA
Sunrise Educational Session: MRI Assessment in Monitoring Cancer Therapy
Sunrise Session

ORGANIZERS: Linda Moy, M.D. & Valeria Panebianco, M.D.

Wednesday, 26 April 2017
Room 314  07:00 - 07:50 Moderators: Sungehon Gene Kim, Valeria Panebianco

Skill Level: Intermediate
Slack Channel: #e_cancer_mol_mrs
Session Number: SW07

Overview
Cancer therapy is based on combinations of conventional therapies in addition to targeted therapies and interventional techniques. Conventional methods - biochemical markers and symptoms assessment do not accurately predict treatment response. Multiparametric MRI, provides anatomical and emerging functional biomarkers that can improve the classification of therapy response that contribute to improved decision making.

Target Audience
Clinicians and M.D. & Ph.D. researchers who will benefit from tool and techniques for noninvasive imaging of tumor response to therapy with MpMRI.

Educational Objectives
Upon completion of this course, participants should be able to:
-Define the role of MRI in the management of patient during oncological treatment;
-Identify the dominant MR technique in the assessment of early efficient response to therapy; and
-Recognize the limitations of current MRI techniques to assess response to targeted therapy.


07:00
 Multiparametric MRI for Tumor Therapy Response - permission withheld
Anwar Padhani
Multiparametric imaging enables biologic assessments of cancer because of its multidimensional nature. Multiparametric imaging enables more accurate detection, localization, characterization & response assessments. §Imaging biomarkers development frameworks are accelerating the adoption of quantitative imaging in drug development and for high precision medicine 
07:25
 Sarcoma Imaging - permission withheld
Laura Fayad
While conventional MRI sequences remain useful, adjunct sequences are now available that are easily integrated into a routine MRI tumor protocol,  to enhance the utility of MRI for disease characterization, assessment of treatment response and the detection of tumor recurrence following surgery.  Specifically, non-contrast MRI techniques (such as quantitative DWI and chemical shift imaging) are fast and non-invasive and provide valuable information for the evaluation of sarcomas. MR spectroscopy is not in common clinical use for the assessment of sarcomas, although it is a technique that may provide information regarding the metabolic pathways of sarcoma development.
07:50
 Adjournment
 
 

The International Society for Magnetic Resonance in Medicine is accredited by the Accreditation Council for
Continuing Medical Education to provide continuing medical education for physicians.